Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9N9T

Crystal structure of Main protease of PEDV in complex with AVI8122

This is a non-PDB format compatible entry.
Summary for 9N9T
Entry DOI10.2210/pdb9n9t/pdb
DescriptorNsp5, N-[(2S)-3-cyclopropyl-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopiperidin-3-yl]butan-2-yl}amino)-1-oxopropan-2-yl]-7-fluoro-1H-indole-2-carboxamide (3 entities in total)
Functional Keywordsmain protease, nsp5, pedv, inhibitor, avi8122, viral protein
Biological sourcePorcine epidemic diarrhea virus
Total number of polymer chains2
Total formula weight66593.37
Authors
Chen, P.,Lu, J.,Lemieux, M.J. (deposition date: 2025-02-11, release date: 2026-02-18, Last modification date: 2026-07-29)
Primary citationChen, P.,Strunk, U.,Arutyunova, E.,Lu, J.,Chen, S.A.,Demmon, S.,Maplethorpe, C.,Kandadai, A.S.,Shields, J.,Saffran, H.A.,Lamer, T.,Fischer, C.,Van Oers, T.J.,Turner, Z.,Leong, P.,Iyyathurai, J.,Young, H.S.,Bai, B.,Vederas, J.C.,Nieman, J.A.,Joyce, M.A.,Tyrrell, D.L.,Lemieux, M.J.
Identification of a Potent Pan-Coronaviral Main Protease Inhibitor.
J.Med.Chem., 2026
Cited by
PubMed Abstract: The global impact of SARS-CoV-2 and the continued emergence of zoonotic coronaviruses underscore the urgent need for broad-spectrum antivirals for pandemic preparedness. Herein, we report , a covalent pan-coronaviral inhibitor that targets 19 Ms across the α, β, γ, and δ genera, encompassing bat, human, and other animal coronaviruses. exhibits low nanomolar potency and favorable pharmacokinetics in mice. Structural studies reveal that forms a covalent bond with the catalytic cysteine and maintains conserved interactions within the active sites of these Ms. , efficiently inhibited the replication of SARS-CoV-2 and its variants of concern as well as the activity of Ms from all four genera. Furthermore, in mouse models, conferred dose-dependent protection against a lethal SARS-CoV-2 infection. Our findings position as an early lead compound and a tractable structural starting point for the development of broad-spectrum antivirals against future coronavirus spillover threats.
PubMed: 42461134
DOI: 10.1021/acs.jmedchem.6c00645
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.5 Å)
Structure validation

257179

PDB entries from 2026-07-29

PDB statisticsPDBj update infoContact PDBjnumon